Medicus Pharma Ltd. (MDCX)
NASDAQ: MDCX · Real-Time Price · USD
0.300
+0.003 (1.01%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Medicus Pharma Statistics

Total Valuation

Medicus Pharma has a market cap or net worth of $11.81 million. The enterprise value is $8.33 million.

Market Cap 11.81M
Enterprise Value 8.33M

Important Dates

The next estimated earnings date is Monday, May 11, 2026, after market close.

Earnings Date May 11, 2026
Ex-Dividend Date n/a

Share Statistics

Medicus Pharma has 39.36 million shares outstanding. The number of shares has increased by 79.68% in one year.

Current Share Class 39.36M
Shares Outstanding 39.36M
Shares Change (YoY) +79.68%
Shares Change (QoQ) -0.16%
Owned by Insiders (%) 9.41%
Owned by Institutions (%) 12.20%
Float 32.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 309.74
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 146.79.

Current Ratio 1.00
Quick Ratio 0.88
Debt / Equity 146.79
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -129.91

Financial Efficiency

Return on equity (ROE) is -2,981.18% and return on invested capital (ROIC) is -357.28%.

Return on Equity (ROE) -2,981.18%
Return on Assets (ROA) -204.05%
Return on Invested Capital (ROIC) -357.28%
Return on Capital Employed (ROCE) -20,793.76%
Weighted Average Cost of Capital (WACC) 3.66%
Revenue Per Employee n/a
Profits Per Employee -$2.96M
Employee Count 16
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -92.41% in the last 52 weeks. The beta is -0.04, so Medicus Pharma's price volatility has been lower than the market average.

Beta (5Y) -0.04
52-Week Price Change -92.41%
50-Day Moving Average 0.64
200-Day Moving Average 1.71
Relative Strength Index (RSI) 32.04
Average Volume (20 Days) 7,403,858

Short Selling Information

The latest short interest is 1.27 million, so 3.22% of the outstanding shares have been sold short.

Short Interest 1.27M
Short Previous Month 3.56M
Short % of Shares Out 3.22%
Short % of Float 3.87%
Short Ratio (days to cover) 0.36

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -25.64M
Pretax Income -47.28M
Net Income -47.28M
EBITDA n/a
EBIT -25.64M
Earnings Per Share (EPS) -$2.74
Full Income Statement

Balance Sheet

The company has $8.71 million in cash and $5.48 million in debt, giving a net cash position of $3.23 million or $0.08 per share.

Cash & Cash Equivalents 8.71M
Total Debt 5.48M
Net Cash 3.23M
Net Cash Per Share $0.08
Equity (Book Value) 37,311
Book Value Per Share -0.00
Working Capital -47,418
Full Balance Sheet

Cash Flow

Operating Cash Flow -22.78M
Capital Expenditures n/a
Depreciation & Amortization n/a
Net Borrowing 4.48M
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Medicus Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -79.68%
Shareholder Yield -79.68%
Earnings Yield -409.13%
FCF Yield n/a

Analyst Forecast

The average price target for Medicus Pharma is $14.50, which is 4,733.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target $14.50
Price Target Difference 4,733.33%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on October 25, 2024. It was a reverse split with a ratio of 1:2.

Last Split Date Oct 25, 2024
Split Type Reverse
Split Ratio 1:2

Scores

Altman Z-Score n/a
Piotroski F-Score 1